Condition: Cadasil · Sponsor: Perminder Sachdev
The aim of this project is to establish an Australian cohort of patients diagnosed with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). This study will examine the clinical features and longitudinal course of CADASIL. Outcome measures include neuropsychological profile, neuroimaging, genetics, blood biomarkers, and retinal imaging.
This description comes directly from the study's public registry record.
Danit Saks, MBMSc, MRes, PhD · 9348 1658 · d.saks@unsw.edu.au
Always discuss trial participation with your own doctor first.
| John Hunter Hospital | Newcastle, New South Wales, Australia | Recruiting |
| Prince of Wales Hospital | Sydney, New South Wales, Australia | Recruiting |
| University of New South Wales | Sydney, New South Wales, Australia | Recruiting |
| Royal Brisbane and Women's Hospital | Brisbane, Queensland, Australia | Not Yet Recruiting |
| Royal Melbourne Hospital | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06148051